Some of the natural compounds described as promising therapeutics to treat BCa or PCa will be indicated, as well as some of their pharmacological activity as modulators of AR and ERα levels and modifiers of their hormonal response. The gene discussed is ESR1; the disease is posterior cortical atrophy.